Dasatinib, sold under the brand name Sprycel among others, is a targeted therapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).
Dasatinib, sold under the brand name Sprycel, is a specific type of medicine that targets certain types of leukemia. It's used for treating chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).